TOKYO -- Nikon has opened new bioimaging laboratories in Japan and the U.S., aiming to tap into increased demand for contract pharmaceutical research as it looks to double sales in the field by fiscal 2028 and develop health care into a new pillar of growth.
Pharmaceuticals
Nikon bolsters drug research hubs in Japan and U.S.
Company looks to tap growth in regenerative medicine and gene therapy
Nikon entered the business of supporting drug discovery using microscopes in 2017, opening its Fujisawa location in 2021. (Photo by Kohei Yamada)
Read Next
Latest on Pharmaceuticals
